| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/29/2008 | CA2214323C Compounds and compositions for delivering active agents |
| 07/29/2008 | CA2203033C Compounds and compositions for delivering active agents |
| 07/29/2008 | CA2192543C Interleukin-5 specific recombinant antibodies |
| 07/29/2008 | CA2160121C T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 07/24/2008 | WO2008089476A1 Monoclonal antibodies recognizing the enterococcus faecium acm protein |
| 07/24/2008 | WO2008089394A2 Mycobacterium tuberculosis persistance genes |
| 07/24/2008 | WO2008089392A2 Attenuated vaccine for tularemia |
| 07/24/2008 | WO2008089281A2 Methods of treating diabetes |
| 07/24/2008 | WO2008089144A2 Improved dna vaccination protocols |
| 07/24/2008 | WO2008089135A2 Identification of biomarkers predictive of dasatinib effects in cancer cells |
| 07/24/2008 | WO2008089070A2 Combination therapy for the treatment of cancer |
| 07/24/2008 | WO2008089022A2 Cd200 and its receptor, cd200r, modulate bone mass via the differentiation of osteoclasts |
| 07/24/2008 | WO2008088983A1 PEGYLATED Aβ FAB |
| 07/24/2008 | WO2008088846A2 Substance p and analogs thereof as an immunogenic composition adjuvant |
| 07/24/2008 | WO2008088822A1 Inhibiting staphylococcus epidermidis infections |
| 07/24/2008 | WO2008088771A2 Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens |
| 07/24/2008 | WO2008088594A2 Isolation of antibodies that cross-react and neutralize rankl orginating from multiple species |
| 07/24/2008 | WO2008088583A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 07/24/2008 | WO2008088426A2 Adherence inhibitor directed to and method of making and using |
| 07/24/2008 | WO2008088410A2 Influencing viral lipid constituents |
| 07/24/2008 | WO2008087219A1 Compositions and methods for regulating t cell activity |
| 07/24/2008 | WO2008087102A1 Vaccine |
| 07/24/2008 | WO2008086984A1 Recombinant malaria vaccine |
| 07/24/2008 | WO2008086813A2 Peptides derived from proteins of the insulin super-family |
| 07/24/2008 | WO2008086612A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/24/2008 | WO2008086610A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/24/2008 | WO2008065378A3 Binding members for interleukin-6 |
| 07/24/2008 | WO2008065378A2 Binding members for interleukin-6 |
| 07/24/2008 | WO2008064306A9 Methods and compositions relating to islet cell neogenesis |
| 07/24/2008 | WO2008057529A9 Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp) |
| 07/24/2008 | WO2008051266A3 A dengue reporter virus and methods of making and using the same |
| 07/24/2008 | WO2008038002A3 T cell therapies |
| 07/24/2008 | WO2008033966A3 Alphavirus replicon particles matched to protein antigens as immunological adjuvants |
| 07/24/2008 | WO2008027338A3 Antagonistic human light-specific human monoclonal antibodies |
| 07/24/2008 | WO2008019162A3 Compositions and methods related to staphylococcal bacterium proteins |
| 07/24/2008 | WO2008017956A3 Frozen stockpiling of influenza vaccines |
| 07/24/2008 | WO2008011609A3 Compositions and methods for vaccinating against hsv-2 |
| 07/24/2008 | WO2008005880A3 Antibodies for norovirus |
| 07/24/2008 | WO2008002319A3 Compositions and methods for inhibition of retroviral infection |
| 07/24/2008 | WO2007149715A3 Novel dna sequences, vectors and proteins of avian influenza hemagglutinin |
| 07/24/2008 | WO2007121184A3 Compounds and methods for diagnosis and treatment of leishmaniasis |
| 07/24/2008 | WO2007092607A3 Treatment of hemorrhagic viral infections using a tissue factor inhibitor |
| 07/24/2008 | WO2007089793A3 Tat-041 and methods of assessing and treating cancer |
| 07/24/2008 | WO2007052058A8 Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
| 07/24/2008 | WO2007022425A9 Influenza recombinant subunit vaccine |
| 07/24/2008 | US20080177047 Somatomedin specific immunoglobulin for use in prevention and treatment of cell proliferative disorders |
| 07/24/2008 | US20080177043 Vascular endothelial growth factor receptor specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders |
| 07/24/2008 | US20080176820 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro |
| 07/24/2008 | US20080176797 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
| 07/24/2008 | US20080176281 Transgenic cell for use as bioreactor in expression of polypeptide for treating arthritis |
| 07/24/2008 | US20080176270 identifying Francisella tularensis vaccine candidates. It enables identification of novel vaccine candidates and quality assurance for vaccine batches, assessment of protection in vaccinates and identification of the infecting agent in vaccinates. Mice were first vaccinated with Brucella infections |
| 07/24/2008 | US20080176268 MN Gene and Protein |
| 07/24/2008 | US20080175971 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 07/24/2008 | US20080175871 Eliciting improved immune responses |
| 07/24/2008 | US20080175870 Human Cancer Stem Cells |
| 07/24/2008 | US20080175869 Mycobacterial sulfation pathway proteins and methods of use thereof |
| 07/24/2008 | US20080175868 Group A streptococcal antigen combined with proteosome adjuvant; prevention or reduction of bacterial colonization of the throat; intranasal administration |
| 07/24/2008 | US20080175867 genetic engineered proteins useful as immunogens in vaccines; prevention of periodontal disease |
| 07/24/2008 | US20080175866 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms |
| 07/24/2008 | US20080175865 inoculation with a mixture of deactivated forms lactobacillus strains |
| 07/24/2008 | US20080175864 administering antiviral agents, very low density lipoproteins (VLDL) assembly inhibitors, such as small interfering RNA or antisense oligonucleotide directed against apolipoprotein B, or microsomal triglyceride transfer protein (MTP) inhibitors, to inhibit release of HCV from an HCV-infected cells |
| 07/24/2008 | US20080175863 immunogens and vaccines comprising myxovirus proteins having amino acid replacements; genetic engineering |
| 07/24/2008 | US20080175862 Recombinant Flavivirus Vaccines |
| 07/24/2008 | US20080175861 Modified polymerases and attenuated viruses and methods of use thereof |
| 07/24/2008 | US20080175860 comprising leptospira cells, attenuated strains of distemper, adenovirus, parainfluenza virus, parvoviruses and carriers, used for inoculating dogs against pathogens |
| 07/24/2008 | US20080175859 Recombinant infectious laryngotracheitis virus and uses thereof |
| 07/24/2008 | US20080175857 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 07/24/2008 | US20080175856 Enterococcus Antigens |
| 07/24/2008 | US20080175855 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; cancer vaccines |
| 07/24/2008 | US20080175854 Point mutations; antibodies; fusion proteins |
| 07/24/2008 | US20080175853 Virus-like particles for the induction of autoantibodies |
| 07/24/2008 | US20080175852 Phosphating a carboxyalkyl halide or sulfonate with a calcium salt of phosphocholine, reacting the carboxy group with a nitrophenyl carboxylate to form, e.g., 4-nitrophenyl-6-(O-phosphocholine)hydroxyhexanoate, and optionally conjugating with an immunogenic carrier having a reactive amino group; vaccines |
| 07/24/2008 | US20080175851 Methods and compositions for enhancing the growth of fish and shellfish |
| 07/24/2008 | US20080175850 Methods for human allografting |
| 07/24/2008 | US20080175849 Monoclonal antibody for use in diagnosis, prevention and treatment of infectious mononucleosis and cell proliferative disorders |
| 07/24/2008 | US20080175848 Reducing matrix protein concentration via enzyme inhibitor and plasmin administration; prevention and treatment of fibrosis; wound healing agent |
| 07/24/2008 | US20080175847 Anti-dll4 antibodies and methods using same |
| 07/24/2008 | US20080175846 Antibodies against cancer antigen tmeff2 and uses thereof |
| 07/24/2008 | US20080175845 Using tumor necrosis factor receptor specific monoclonal antibody as therapeutic for treatment and prevention of inflammatory disorders |
| 07/24/2008 | US20080175844 Activin-like receptor kinase immunoglobulin fusion for prevention and treatment of cell proliferative and vision defects; angiogenesis inhibitors |
| 07/24/2008 | US20080175843 Nucleotide sequences coding osteoblast activating factor (OAF) for use in diagnosis, prevention and treatment of inflammatory, periodontal and infectious diseases |
| 07/24/2008 | US20080175842 Compositions and methods for treatment |
| 07/24/2008 | US20080175841 Antagonistic Anti-hTNFSF13b Human Antibodies |
| 07/24/2008 | US20080175840 Methods for treating angiogenesis related disorders |
| 07/24/2008 | US20080175839 Compositions Against Cancer Antigen LIV-1 and Uses Thereof |
| 07/24/2008 | US20080175838 Using alpha-synuclein specific monoclonal antibody to diagnose, prevent amd treat parkinson's disease |
| 07/24/2008 | US20080175837 Autophagy regulators; drug screening; dipeptidyl peptidase IV (Dpp4); preservative of organs for transplantation |
| 07/24/2008 | US20080175836 Using human immunodeficiency viral nucleotide sequences as tool in developing vaccines against HIV infection |
| 07/24/2008 | US20080175835 A beta -derived diffusible ligands (ADDL) specific immunoglobulin for use in prevention and treatment of alzheimer's diseases |
| 07/24/2008 | US20080175814 Quinoline derivatives for modulating dna methylation |
| 07/24/2008 | US20080175797 Preventing airway mucus production by administration of egf-r antagonists |
| 07/24/2008 | US20080175788 Analyzing for changes in levels of cancer specific genes (CSG) in cells, tissues or bodily fluids compared with levels of CSG in preferably the same cells, tissues, or bodily fluid type of a normal human control: administering antibodies conjugated to cytotoxic agents, which specifically bind CSG |
| 07/24/2008 | CA2676308A1 Recombinant malaria vaccine |
| 07/24/2008 | CA2675847A1 Pegylated a.beta. fab |
| 07/24/2008 | CA2675411A1 Posaconazole polymer conjugates and methods of treatment using posaconazole and polymer conjugates thereof |
| 07/24/2008 | CA2674578A1 Cd200 and its receptor, cd200r, modulate bone mass via the differentiation of osteoclasts |
| 07/24/2008 | CA2674552A1 Vaccine |
| 07/24/2008 | CA2673994A1 Lentivirus pseudotyped with influenza hemagglutinin and methods of use |
| 07/24/2008 | CA2661651A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |